• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Polymeric nanoparticles transport quantum dots into cells

November 1, 2016 By Sarah Faulkner

Polymeric nanoparticles transport quantum dots into cellsResearchers from the University of Tokyo treated the surfaces of nanoparticles with polymers and enabled the transport of quantum dots into cells, according to a study published in Science and Technology of Advanced Materials.

By coating nanoparticles with MPC polymers, researchers can make substances that are easily transported and delivered into the blood or other tissue because the polymer mimics cellular membranes. Nanoparticles treated with MPC polymers can be used as anti-tumor compounds, gene carriers, and contrast agents to improve MRI images, according to the study.

Researchers at the University of Tokyo used the polymeric nanoparticles to transport quantum dots, a nanoparticle made of semiconducting material, into cells. Using a solvent-evaporation technique, the team was able to create polymeric nanoparticles with a core of quantum dots. The particles can outperform conventional organic fluorescent dyes in biomedical imaging, according to the team. The particles maintained the same levels of fluoresence in solution after being stored for more than six months at 4 °C and in environments of varying acidity.

Conventional dyes lose their fluorescence over time with repeated illumination, but the polymeric nanoparticles filled with quantum dots did not.

The team also showed that when they attached a cell-penetrating peptide called R8 to the polymeric nanoparticles, the particles were taken up by the cells within 5 hours and had no inflammatory effect on the cells after several days. The

“This was the first report showing the long-term retention of nanoparticles in cells,” lead researcher Kazuhiko Ishihara said in prepared remarks. “Preparation of bioactive nanoparticles with MPC polymers can be used to fabricate in-cell nanodevices whose interaction with cells can be completely controlled.”

Filed Under: Featured, Nanoparticles, Research & Development Tagged With: University of Tokyo

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS